
WASHINGTON, Dec. 29 (UPI) -- Novartis's cancer drug Femara has been approved for the expanded use of treating early breast cancer.
The Food and Drug Administration has cleared Femara for the new indication of treating some women with early breast cancer immediately after surgery, which is also called early adjuvant therapy.
Femara -- belonging to a class of drugs called aromase inhibitors -- may now be used as therapy for post-menopausal women with early, hormone-positive breast cancer -- or the type of breast cancer whose growth is fueled by estrogen -- immediately following surgery.
Novartis's drug was previously approved by the FDA to treat patients with advanced breast cancer and those who have had surgery followed by five years of treatment with tamoxifen, the current standard of care.
Current studies suggest that Femara is superior to tamoxifen in protecting against the return of breast cancer after surgery.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, May 27 (UPI) --
President Obama has put U.S. foreign policy on auto-pilot while he concentrates on getting re-elected, a senior Republican senator said Sunday.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption